VMD VIEMED HEALTHCARE, INC. Insider Trading

VMD President Moore Michael sold 136,802 shares across 3 days (Mar 18-20) for $1,237,976.12 at avg $9.05, retaining 1,585,812 shares

Moore Michael executed 3 separate sales totaling 136,802 shares for $1,237,976.12 between March 18–20, 2026, reducing his holdings by 7.9%. The sales occurred at prices ($9.42, $9.21, $8.77) near the 52-week high of $9.78, with the blended average of $9.05 substantially above the current price of $8.71 and trading meaningfully above VMD's recent 90-day gain of +17.4%. His prior 3 sales at VMD (June–July 2025) were all well-timed at the 90-day mark, producing returns of -10.7%, -10.8%, and -12.6%, establishing a consistent pattern of selling before subsequent declines. Against this backdrop, the timing of these March sales—at elevated prices following the company's strong +20.5% annual revenue growth—warrants tracking to see whether this transaction proves similarly predictive of near-term weakness.

VMD President Michael Moore sells 181,316 shares across 3 transactions for $1,255,493.37; holdings cut 50.5%

Moore Michael, President of Viemed Healthcare, executed 3 separate sales totaling 181,316 shares for $1,255,493.37 between June 27 and June 30, 2025, reducing his holdings from 358,749 to 177,433 shares—a 50.5% reduction in position size. The blended average sale price of $6.92 sits 26.4% below the 52-week high of $9.51, representing a substantial liquidation during a period when the stock is off its yearly peak. Given that the company reported $59.1M in quarterly revenue with 22.5% annual growth and a P/E of 22.58, the context is a fundamentally growing business; the magnitude of this single-event liquidation—cutting holdings in half—warrants investor attention to determine whether this reflects planned capital deployment by management or a departure from prior conviction levels.